Vera Miranda-Gonçalves

Scopus Author ID Ciência ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 12

Top Venues

Molecular oncology

Journal of experimental & clinical cancer research : CR

Journal of personalized medicine

Cancers

IPO-Porto

University of Minho (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IPO-Porto

Portugal

Pos-Doc :: Research Centre of IPO-Porto

University of Minho

Portugal

PhD student :: Life and Health Sciences Research Institute

University of Minho

Portugal

Fellowship Researcher :: Life and Health Sciences Research Institute (ICVS)

Education History

University of Minho

Portugal

PHD :: School of Medicine

University of Minho

Portugal

MSC :: School of Medicine

University of Coimbra

Portugal

BSC :: Faculty of Siencies and Technologies

Publications

Eduarda P Martins, Céline S Gonçalves, Marta Pojo, Rita Carvalho, Ana S Ribeiro, Vera Miranda-Gonçalves, Ricardo Taipa, Fernando Pardal, Afonso A Pinto, Carlos Custódia, Claudia C Faria, Fátima Baltazar, Nuno Sousa, Joana Paredes, Bruno M Costa
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular oncology 16 (14) (2022)
Cláudia Martins-Lima, Vera Miranda-Gonçalves, João Lobo, Vera Constâncio, Pedro Leite-Silva, Catarina Guimarães-Teixeira, Sara Monteiro-Reis, José Pedro Sequeira, Mariana Cantante, Céline S Gonçalves, Bruno M Costa, Rui M Henrique, Carmen Jerónimo
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression. Cellular oncology (Dordrecht) 45 (1) (2022)
Catarina Guimarães-Teixeira, João Lobo, Vera Miranda-Gonçalves, Daniela Barros-Silva, Cláudia Martins-Lima, Sara Monteiro-Reis, José Pedro Sequeira, Isa Carneiro, Margareta P Correia, Rui M Henrique, Carmen Jerónimo
Downregulation of m 6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness. Molecular oncology 16 (9) (2022)
Beatriz Chaves Lourenço, Catarina Guimarães-Teixeira, Bianca de Cássia Troncarelli Flores, Vera Miranda-Gonçalves, Rita Guimarães, Mariana Cantante, Paula Lopes, Isaac Braga, Joaquina Maurício, Carmen Jerónimo, Rui M Henrique, João Lobo
Ki67 and LSD1 Expression in Testicular Germ Cell Tumors Is Not Associated with Patient Outcome: Investigation Using a Digital Pathology Algorithm. Life (Basel, Switzerland) 12 (2) (2022)
João Lobo, Vera Constâncio, Catarina Guimarães-Teixeira, Pedro Leite-Silva, Vera Miranda-Gonçalves, José Pedro Sequeira, Laura Pistoni, Rita Guimarães, Mariana Cantante, Isaac Braga, Joaquina Maurício, Leendert H J Looijenga, Rui M Henrique, Carmen Jerónimo
Promoter methylation of DNA homologous recombination genes is predictive of the responsiveness to PARP inhibitor treatment in testicular germ cell tumors. Molecular oncology 15 (4) (2021)
João Lobo, Ana Rita Cardoso, Vera Miranda-Gonçalves, Leendert H J Looijenga, Marie Lopez, Paola B Arimondo, Rui M Henrique, Carmen Jerónimo
Targeting Germ Cell Tumors with the Newly Synthesized Flavanone-Derived Compound MLo1302 Efficiently Reduces Tumor Cell Viability and Induces Apoptosis and Cell Cycle Arrest. Pharmaceutics 13 (1) (2021)
Catarina Guimarães-Teixeira, Daniela Barros-Silva, João Lobo, Diana Soares-Fernandes, Vera Constâncio, Pedro Leite-Silva, Rui Silva-Santos, Isaac Braga, Rui M Henrique, Vera Miranda-Gonçalves, Carmen Jerónimo
Deregulation of N6-Methyladenosine RNA Modification and Its Erasers FTO/ALKBH5 among the Main Renal Cell Tumor Subtypes. Journal of personalized medicine 11 (10) (2021)
Vera Miranda-Gonçalves, Céline S Gonçalves, Sara Granja, Joana Vieira de Castro, Rui Manuel Vieira Reis, Bruno M Costa, Fátima Baltazar
MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. Cancers 13 (14) (2021)
Vera Miranda-Gonçalves, João Lobo, Catarina Guimarães-Teixeira, Daniela Barros-Silva, Rita Guimarães, Mariana Cantante, Isaac Braga, Joaquina Maurício, Christoph Oing, Friedemann Honecker, Daniel Nettersheim, Leendert H J Looijenga, Rui M Henrique, Carmen Jerónimo
The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Filipa Quintela Vieira, Ângela Marques-Magalhães, Vera Miranda-Gonçalves, Ricardo Ferraz, Mónica Vieira, Cristina Prudêncio, Carmen Jerónimo, Regina Augusta Silva
The Impact of [C16Pyr][Amp] on the Aggressiveness in Breast and Prostate Cancer Cell Lines. International journal of molecular sciences 21 (24) (2020)
Ana Rita Cardoso, João Lobo, Vera Miranda-Gonçalves, Rui M Henrique, Carmen Jerónimo
Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of 'epidrugs'. Epigenetics 16 (4) (2020)
Ana Lameirinhas, Vera Miranda-Gonçalves, Rui M Henrique, Carmen Jerónimo
The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma. Genes 10 (4) (2019)

Vera Miranda-Gonçalves.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vera Miranda-Gonçalves